Clinical Trial Update: A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit [NA]

View source ↗

Summary

A completed 6-month clinical trial comparing infliximab to placebo in patients with undifferentiated arthritis at high risk of rheumatoid arthritis, with report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Undifferentiated Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Patrick Durez | Conditions: Undifferentiated Arthritis | NA | Status: COMPLETED